AXIOS CHINA (E7148)

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

December 24, 2020

Study Completion Date

October 30, 2021

Conditions
Pancreatic Pseudocyst and Walled-off Necrosis
Interventions
DEVICE

HOT AXIOS Stent and Electrocautery- Enhanced Delivery System

The HOT AXIOS Stent and Electrocautery- Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst or a walled-off necrosis with ≥ 70% fluid content.

Trial Locations (1)

100000

Beijing Friendship Hospital, Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT03808272 - AXIOS CHINA (E7148) | Biotech Hunter | Biotech Hunter